Bisserier, M., Milara, J., Abdeldjebbar, Y., Gubara, S., Jones, C., Bueno-Beti, C., . . . Hadri, L. (2020). AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis. Mol Ther.
استشهاد بنمط شيكاغوBisserier, Malik, et al. "AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis By Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis." Mol Ther 2020.
MLA استشهادBisserier, Malik, et al. "AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis By Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis." Mol Ther 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.